SynthesisFrontiers in immunology2022

A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer.

Taihang Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.